AgosinM.ChristenR.BadinezO.GasicG.NeghmeA.PizarroO.JarpaA: Cortisone induced metastases of adenocarcinoma in mice. Proc. Soc. Exper. Biol. and Med.80 (1952), 128.
2.
BasergaR.ShubikP.: The action of cortisone on transplanted and induced tumors in mice. Cancer Res.14 (1954), 12.
3.
BauerK. H.: Das Krebsproblem. Springer-Verlag, Berlin. Göttingen. Heidelberg. 1949.
4.
HansenP. BjerreBichelJ.: Triaetylen-melamin-behandling af malign granulomatose og enkelte andre maligne lidelser. Nordisk Medicin47 (1952), 58.
5.
BondW. H.RohnR. J.DykeR. W.FoutsP. J.: Clinical use of triethylene melamine, report of 75 cases. Arch. Int. Med.91 (1953), 602.
6.
BoylandE.: Effects of chlorethylamines on tumours with special reference to bronchogenic carcinoma. Brit. J. Cancer.2 (1948), 17.
DiamondHenry D.: The medical management of cancer. Grune and Stratton, New York and London 1958.
9.
FriedenbergR. M.RubenfeldS.: Role of cortisone in preventing pulmonary fibrosis following irradiation. Am. J. Roentgenol.72 (1954), 271.
10.
GasicG. Wu. S. H.BaydakT.: Effect of cortisone upon growth of primary mouse tumours produced by inoculi of different size. Seventh Intern. Cancer Congress London 1958. Abstracts of Papers p. 255.
11.
GrahamJ. B.GrahamR. M.: Modification of resistance of ionizing radiation by humoral agents. Cancer3 (1950), 709.
12.
HoughtonL. E.WalterJ. B.JonesD. E. A.: Inhibition of acute x-ray damage by cortisone. Brit. Med. J.2 (1954), 1313.
13.
IversenH.G.: The influence of cortisone on the frequency of tumour metastases. Acta Path. et Microbiol. Scandinav.41 (1957), 273.
14.
IversenH.G.HjortG. H.: The influence of corticoid steroids on the frequency of spleen metastases in patients with breast cancer. Acta Path. et Microbiol. Scandinav.44 (1958), 205.
15.
KarnofskyD. A.BurchenalJ. H.ArmisteadG. C.SouthamC. M.BernsteinJ. L.CraverJ. F.RhoadsC. P.: Triethylene melamine in treatment of neoplastic disease; A compound with nitrogen-mustard—like activity suitable for oral and intravenous use. Arch. Int. Med.87 (1951), 477.
16.
KarnofskyDavid A.MyersW. P. LairdPhillipsRalph: Treatment of inoperable pulmonary cancer, primary and metastatic. Am. J. Surg.89 (1955), 526.
17.
KligermanMorton M.ShapiroDaniel M.: Augmentation of radiotherapeutic effect by cancer chemotherapy. Radiology69 (1957), 194.
18.
LapisK.NémethL.: Effect of various chemotherapeutic agents on metastasis. Brit. J. Cancer.10 (1956), 719. (Abstr.: Yearbook Cancer 1957–58, p. 388).
19.
LapisK.StarkE.: Hormonal influencing of metastasis formation in experimental tumours. Seventh Intern. Cancer Congress, London 1958. Abstr. of Papers p. 100.
20.
MarshallA. H. E.: The action of cortisone on experimental acute roentgen dermatitis. Acta Radiol.39 (1953), 73.
21.
McCarthyWilliamD.: Palliation and remission of cancer with combined cortisteroid and nitrogen mustard therapy. Report of 100 cases. New England J. Med.252 (1955), 467 and Yearbook Cancer 1956–57, p. 398.
22.
PlenkHenry P.FusonRogerSorensenFred. M.: The nature of the effect of ACTH and cortisone on tumor growth in irradiated animals. Radiology72 (1959), 75.
23.
RoswitB.KaplanG.: Role of nitrogen mustard (HN2) as a systemic adjunct to the radiation therapy of certain malignant diseases. Am. J. Roentgenol.61 (1949), 626.
24.
RoswitB.KaplanG.: Nitrogen mustard as an adjunct to radiation in the management of bronchogenic cancer. Radiology57 (1951), 384.
25.
RoswitBernhard: Present status of chemotherapy of bronchial cancer. Radiology69 (1957), 499.
26.
SalineM.BaumG. L.: Triethylene melamine in bronchogenic carcinoma with vena caval obstruction. J.A.M.A.156 (1954), 1493.
27.
SchultzMilford D.: Radiotherapy in advanced and incurable malignant disease. Radiology69 (1957), 321.
28.
SchultzMilford D.: The results of radiotherapy in cancer of the lung. Radiology69 (1957), 494.
29.
StollB. A.: Nitromin and prednisolone in the treatment of advanced cancer. Seventh International Cancer Congress, London 1958. Abstr. of Papers p. 293.
30.
ThomasSydney F.: Combined therapy: Radiation and chemicals. Radiology69 (1957), 204.
31.
VidebækÅ.: On the use of nitrogen mustard as a therapeutic agent. Acta Med. Scandinav.135 (1949), 47.
32.
WhiteheadRichard W.LanierR. R.ThompsonJ. B.: The combined effect of radiogold and nitrogen mustard and radiogold and certain other compounds on the Ehrlich ascites carcinoma. Cancer11 (1958), 929.
33.
WrightJ. C.PrigotAa.WhrightL. T.AronsJ.: Further observations on the use of triethylene melamine in neoplastic diseases. Arch. Int. Med.89 (1952), 387.